(Alliance News) - The FTSE 100 opened in the decline on Thursday, despite gains from insurance firms, though peers in Europe were on the rise. Read More
(Alliance News) - The FTSE 100 made steady progress on Wednesday, pushing back towards record highs, as hopes grew that the US Federal Reserve will lower interest rates in the coming months. Read More
(Alliance News) - British Land Co PLC on Wednesday said it signed nine new UK-based biotech and health tech startups for its new co-working lab space adjacent to Regent's Place. Read More
(Alliance News) - London's FTSE 100 outperformed on Monday, sitting solidly higher in afternoon dealings, though stocks in mainland Europe faded. Read More
(Alliance News) - GSK PLC on Monday said its gepotidacin drug has been accepted for priority review in the US as an oral option for the treatment of a form of sexually transmitted infection gonorrhoea. Read More
(Alliance News) - Plus500 announced USD165.0 million of new shareholder returns, while Marshalls maintained its profit outlook, anticipating "no improvement in market activity levels" in the remainder of the year. Read More
(Alliance News) - The FTSE 100 edged down on Friday, on a mixed day for European equities, despite new optimism for an end to the war between Russia and Ukraine. Read More
(Alliance News) - GSK PLC on Friday said it will receive an upfront payment of USD370 million from CureVac BV, following a patent settlement involving BioNTech SE and Pfizer Inc over messenger ribonucleic acid vaccine technology. Read More
(Alliance News) - London stocks were called to open higher on Friday, as new data showed soft retail footfall figures during July and US President Donald Trump selected his economic advisor Stephen Miran to fill a Federal Reserve board vacancy. Read More
(Alliance News) - The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs data fuelled concerns as to the strength of the US economy. Read More
(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More
(Alliance News) - The FTSE 100 went into the afternoon lower on Wednesday, though blue-chip peers in Europe were on the up and stocks in New York are called to open higher with a decisive few days on the horizon stateside. Read More
(Alliance News) - GSK said it expects annual sales growth at the top end of its outlook range, after "another quarter of excellent performance" saw revenue and profit beat forecasts. Read More
(Alliance News) - GSK predicted an annual outturn at the top end of guidance, BAE Systems maintained its outlook, while Aston Martin softened its profit forecast. Read More
(Alliance News) - Equities in Europe started the week strongly, after the US and EU agreed a trade deal and on hope that the Donald Trump administration can extend a tariff pause with China. Read More
(Alliance News) - GSK PLC on Monday said it has teamed up with China's Jiangsu Hengrui Pharmaceuticals Co Ltd in a deal worth up to USD12 billion to develop 12 medicines. Read More
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Read More
(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US regulator. Read More
